Medicine & Pharmaceuticals 

LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum

LevEllis, Inc. a pioneering skincare company founded by renowned surgeon and molecular biologist, Laura Ellis, MD, and guided by a distinguished scientific advisory board, is excited to announce the official launch of...

LevEllis, Inc. Announces the Launch of PROVOQUE™: A Revolutionary Regenerative Skincare Serum
Medline launches new ComfortTemp® Patient Warming System with blankets and gowns

Medline today officially announced the launch of the ComfortTemp® Patient Warming System, including disposable blankets and gowns, a product designed to improve upon similar systems on the market and provide unparalleled...

Medline launches new ComfortTemp® Patient Warming System with blankets and gowns
Loopback Analytics Named to Dallas Business Journal's Fast 50 List for Second Consecutive Year

Loopback Analytics, a healthcare data and services company accelerating access and outcomes in specialty care, has been named to the Dallas Business Journal's Fast 50 list for the second year in a row. The annual list...

Loopback Analytics Named to Dallas Business Journal's Fast 50 List for Second Consecutive Year
Medline expands partnership with Emerald Healthcare to include environmental services

Medline today announced a new contract to be the primary supplier of environmental services (EVS) supplies to Emerald Healthcare, which includes 17 facilities across Oklahoma, Nebraska, Kansas and Kentucky.

Medline expands partnership with Emerald Healthcare to include environmental services
miraDry® Secures EU MDR Certification and Expands Indications for Sweat, Odor, and Hair Reduction Across Europe

miraDry®, Inc., a global leader in underarm sweat and odor treatment, announced today it has now obtained CE marking for the miraDry system, under the European Union's Medical Device Regulation (EU MDR 2017/745), along...

miraDry® Secures EU MDR Certification and Expands Indications for Sweat, Odor, and Hair Reduction Across Europe
Canary Speech Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity

Canary Speech, the leading AI-powered voice biomarker health tech company, today announced its Canary Speech Technology and Services Platform residing at Azure Cloud Services (Azure) has earned certified status by HITRUST...

Canary Speech Achieves HITRUST e1 Certification Demonstrating Foundational Cybersecurity
Alcami Announces Key Leadership Appointments in Drug Product Manufacturing

Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced several strategic leadership appointments within its Drug Product team. These appointments, reporting...

Alcami Announces Key Leadership Appointments in Drug Product Manufacturing
Invisible Wounds Foundation Appoints Internationally Renowned TBI Expert as Its Chief Medical Scientist

Invisible Wounds Foundation is pleased to announce the appointment of Dr. James P. Kelly, MA, MD, FAAN, FANA, as its inaugural Chief Medical Scientist. As one of the leading international experts on traumatic brain injury,...

Invisible Wounds Foundation Appoints Internationally Renowned TBI Expert as Its Chief Medical Scientist
CareONE Concierge Now Accepting Candidates for Alzheimer's Device Study

CareONE Concierge has announced the launch of a new research study to evaluate an innovative wearable device aimed at addressing cognitive symptoms associated with Alzheimer's-related dementia. The study will utilize...

CareONE Concierge Now Accepting Candidates for Alzheimer's Device Study
Mental Health and Financial Assistance Made Available for Texans Affected by Floods

In the wake of the tragic flooding that has swept across Central Texas, TimelyCare, higher education's most trusted virtual care provider, is expanding its response to support impacted individuals with both emotional...

Mental Health and Financial Assistance Made Available for Texans Affected by Floods
Dymicron Granted IDE Approval for Triadyme-C Artificial Disc

Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption...

Dymicron Granted IDE Approval for Triadyme-C Artificial Disc
Medicare at 60 Years Old: Eight in 10 Americans Not Yet Enrolled Worry the Program Won't be There for Them

eHealth, Inc. (Nasdaq: EHTH), a leading online private health insurance marketplace, and Retirable today released new original research showing most Americans are worried about the long-term health of both Medicare and...

Medicare at 60 Years Old: Eight in 10 Americans Not Yet Enrolled Worry the Program Won't be There for Them
Can Early Intervention Prevent Leukemia? New Trial Gives Patients a Choice Beyond the Current 'Wait and See' Approach

Break Through Cancer, a Boston-based cancer research foundation, has launched a clinical trial to evaluate the feasibility of early intervention for Clonal Hematopoiesis (CH), a precursor to acute myeloid leukemia (AML)....

Can Early Intervention Prevent Leukemia? New Trial Gives Patients a Choice Beyond the Current 'Wait and See' Approach
New TriNetX Survey Reveals Biopharma's Bold Embrace of Real-World Data and Artificial Intelligence--But Warns of Looming Barriers

As biopharmaceutical companies double down on innovation and patient-centric research, a new industry survey from studioID and TriNetX reveals widespread integration of RWD and AI in drug development but also exposes...

New TriNetX Survey Reveals Biopharma's Bold Embrace of Real-World Data and Artificial Intelligence--But Warns of Looming Barriers
Flow Sciences Announces Executive Leadership Reorganization

Flow Sciences, Inc., a global leader in high-performance containment solutions, today announced a significant reorganization of its executive leadership team to position the company for continued innovation and growth.

Flow Sciences Announces Executive Leadership Reorganization
apree health Appoints Marla McLaughlin as Chief Medical Officer

apree health, a Mosaic Health company, and the leader in transformative healthcare solutions, today announced that Marla McLaughlin, MD has been named chief medical officer (CMO) for the company and its Castlight Health...

apree health Appoints Marla McLaughlin as Chief Medical Officer
CS Genetics Launches 96-Sample SimpleCell™ Kit, Delivering Same-Day Single Cell RNA-Seq at Population Scale

CS Genetics, a privately held genomics technology company, today announced the commercial launch of its 96-sample SimpleCell 3' Gene Expression Kit, further expanding the capabilities of its SimpleCell platform for...

CS Genetics Launches 96-Sample SimpleCell™ Kit, Delivering Same-Day Single Cell RNA-Seq at Population Scale
AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

AbbVie (NYSE: ABBV) and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGI's lead investigational asset,...

AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
Laborie's Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan

Effective July 1, 2025, Blue Cross Blue Shield of Michigan (BCBSM) has issued a new medical policy under CPT code 52284, extending coverage for Laborie Medical Technologies' Optilume® Urethral Drug-Coated Balloon for...

Laborie's Optilume® Drug-Coated Balloon for Stricture Secures Coverage from BCBS of Michigan
Labcorp Declares Quarterly Dividend

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The...

Labcorp Declares Quarterly Dividend
MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption

PITTSBURGH, July 10, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced the appointment of Dr. Julia Wright, MD, FACP, as its new Chief Medical...

MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption
Turbine Expands Scientific Advisory Board to Put Virtual Disease Models in Every Scientist's Hands

Turbine, the company virtualizing experiments with AI to accelerate discovery and clinical decisions, today announced the addition of Andrew Pape, PhD and Gregory Vladimer, PhD to its Scientific Advisory Board. Together,...

Turbine Expands Scientific Advisory Board to Put Virtual Disease Models in Every Scientist's Hands
Vibra Hospital of the Central Dakotas to Relocate and Expand Services in Bismarck

Vibra Healthcare, a national leader in specialty hospital care, has announced plans to relocate Vibra Hospital of the Central Dakotas from Mandan, North Dakota, to a new facility under development at 829 NE 43rd Ave. in...

Vibra Hospital of the Central Dakotas to Relocate and Expand Services in Bismarck
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")

Klotho Neurosciences, Inc. (Nasdaq: KLTO), a gene and cell therapy company focused on the treatment of neurodegenerative and other aging-related diseases, today announced that the U.S. Food and Drug Administration (FDA)...

Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025

Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, August 7, 2025. The Company will hold a conference call with...

Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
Taiho Oncology and Taiho Pharmaceutical Announce U.S. FDA Acceptance of Supplemental New Drug Application for INQOVI® in Combination with Venetoclax to Treat Patients with Acute Myeloid Leukemia

Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that the U.S. Food and Drug Administration (FDA) has accepted their supplemental new drug application (sNDA) for INQOVI (decitabine and...

Taiho Oncology and Taiho Pharmaceutical Announce U.S. FDA Acceptance of Supplemental New Drug Application for INQOVI® in Combination with Venetoclax to Treat Patients with Acute Myeloid Leukemia
Sidney and Caroline Kimmel Invest in the Future of Care and Discovery at Jefferson

Thomas Jefferson University and Jefferson Health proudly announced a transformative $28 million gift from Sidney Kimmel, the Philadelphia-born businessman, philanthropist, and film producer, and his wife, Caroline,...

Sidney and Caroline Kimmel Invest in the Future of Care and Discovery at Jefferson
26Health Opens The Venus Center: Expanding Access to Reproductive Healthcare in Orlando!

26Health is proud to announce the launch of The Venus Center, a dedicated reproductive and sexual healthcare facility that will officially open to the public on July 26, 2025, during the organization's 26Health Fest...

26Health Opens The Venus Center: Expanding Access to Reproductive Healthcare in Orlando!
Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)

Norgine, a leading European specialty pharmaceutical company, is pleased to announce that Swissmedic has approved the registration of IFINWIL® (eflornithine) as monotherapy for the treatment of paediatric patients from one...

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)
Exactech Announces FDA Clearance of First-to-Market Scapula Reconstruction System for Acromial Stress Fractures

Exactech, a global medical technology leader, announced the Equinoxe® Scapula Reconstruction System for acromial and scapular spine fractures has received 510(k) clearance1 from the U.S. Food and Drug Administration,...

Exactech Announces FDA Clearance of First-to-Market Scapula Reconstruction System for Acromial Stress Fractures
Standard Process Introduces Whole Food Folate™

Standard Process®, a pioneer in whole food-based nutritional supplements for over 95 years, proudly announces the release of Whole Food Folate™ - a one-of-a-kind supplement that delivers vitamin B12 and multiple forms of...

Standard Process Introduces Whole Food Folate™
Densitas: AI Identifies Persistent Mammography Positioning Challenges Impacting Screening Quality and Cancer Detection

Groundbreaking Multicenter MAMMO.IQ study demonstrates Densitas intelliMammo® plays a vital role in quantifying and identifying unmet positioning quality criteria.

Densitas: AI Identifies Persistent Mammography Positioning Challenges Impacting Screening Quality and Cancer Detection
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is projected to rise in the coming decades (https://ibn.fm/dyQrw). By 2050,...

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
AbsoluteCare Names William Guptail as President of AbsoluteCare Pharmacy

AbsoluteCare, a leading provider of value-based care for the most medically complex and socially vulnerable individuals, announces the appointment of William "Bill" Guptail as President of AbsoluteCare Pharmacy.

AbsoluteCare Names William Guptail as President of AbsoluteCare Pharmacy
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the Lumipulse® G pTau 217/ß-Amyloid...

Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
Study Finds NuLiv Science Ingredient, Astrion®, Supports Skin Health and Quality

NuLiv Science, a leading plant-based nutraceutical ingredients company enabling people to lead healthier lives, announced the release of a study examining the efficacy and safety of Astrion® (Astragalus membranaceus and...

Study Finds NuLiv Science Ingredient, Astrion®, Supports Skin Health and Quality
FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Kisunla (donanemab-azbt), Lilly's...

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease
Yale School of Medicine Receives $27.7 Million Grant Toward Autism Research

Yale School of Medicine (YSM) was awarded a $27.7 million grant from Aligning Research to Impact Autism (ARIA) to develop an interdisciplinary research project to investigate non-invasive functional communication methods...

Yale School of Medicine Receives $27.7 Million Grant Toward Autism Research
WelbeHealth Names Dr. David Hirota as Chief Medical Officer

Today, the physician-led senior health services provider, WelbeHealth, announced the promotion of David Hirota, MD, FACP, to Chief Medical Officer (CMO). Dr. Hirota, a senior clinical leader within WelbeHealth, is uniquely...

WelbeHealth Names Dr. David Hirota as Chief Medical Officer
Children's Hospital of Philadelphia Researchers Find Children's Health Broadly Declining in the United States

A new study led by researchers at Children's Hospital of Philadelphia (CHOP) has found that children's health in the United States is declining across several key measurements ranging from increased chronic...

Children's Hospital of Philadelphia Researchers Find Children's Health Broadly Declining in the United States
Job Satisfaction Under Pressure: Survey of 528 Life Science Professionals Reveals Impact of Budget Cuts, Workload Increases, and Career Uncertainty

BioInformatics, a Science and Medicine Group company, has released the latest edition of its free monthly Beyond the Bench report, highlighting the state of job satisfaction among scientists and life science professionals...

Job Satisfaction Under Pressure: Survey of 528 Life Science Professionals Reveals Impact of Budget Cuts, Workload Increases, and Career Uncertainty
ChristianaCare and Children's Hospital of Philadelphia Agree to Join Forces, Expand Access to World-Class Pediatric Care in Delaware

ChristianaCare and Children's Hospital of Philadelphia (CHOP) today announce a new strategic affiliation to expand access to world-class pediatric care in Delaware and surrounding communities.

ChristianaCare and Children's Hospital of Philadelphia Agree to Join Forces, Expand Access to World-Class Pediatric Care in Delaware
WellBe Senior Medical Welcomes Dr. Michael Le as New President

WellBe Senior Medical has announced the appointment of Dr. Michael Le as the company's first President. Dr. Le brings more than 25 years of leadership experience in both clinical and operational teams within the...

WellBe Senior Medical Welcomes Dr. Michael Le as New President
Technimark Unveils New Brand Identity: "We Make What Makes Life Better"

Technimark, a world leader in manufacturing for healthcare, consumer packaging, and industrial sectors, today launched a new brand identity to reflect the company's transformation into a global manufacturing leader,...

Technimark Unveils New Brand Identity: "We Make What Makes Life Better"
Jimini Health Releases Technical Blueprint for Safe Patient-Facing AI & Adds DeepMind and Yale Leaders to Advisory Board

Jimini Health, a safety-first AI-powered mental health platform that improves access and efficacy for patients, today released a new white paper titled "A Clinical Safety Framework for AI in Mental Health." Therapy and...

Jimini Health Releases Technical Blueprint for Safe Patient-Facing AI & Adds DeepMind and Yale Leaders to Advisory Board
Wellstar Selects Ketul J. Patel to Lead Next Chapter of PeopleCare

The Wellstar Board of Trustees has selected Ketul J. Patel to become Wellstar Health System's next president and chief executive officer. Patel currently serves as CEO of Virginia Mason Franciscan Health and president...

Wellstar Selects Ketul J. Patel to Lead Next Chapter of PeopleCare
Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the successful completion of the first patient treated with PearlMatrix™ P-15 Peptide...

Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval
Q'Apel Medical Announces U.S. FDA Clearance for the Zebra Neurovascular Access System and Prepares for Full U.S. Launch

Q'Apel Medical (Q'Apel), a private medical device company focused on revolutionizing neurovascular interventions, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its Zebra...

Q'Apel Medical Announces U.S. FDA Clearance for the Zebra Neurovascular Access System and Prepares for Full U.S. Launch
Comar Sets the Standard with CE UDI Labeling Capability and EU MDR Compliance

Comar, a leader in healthcare packaging, has achieved CE certification under the EU Medical Device Regulation (EU MDR 2017/745), reaffirming its commitment to regulatory excellence, patient safety, and market leadership....

Comar Sets the Standard with CE UDI Labeling Capability and EU MDR Compliance
Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery

Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo classification and marketing...

Fziomed Gains FDA De Novo Classification Grant and Marketing Authorization for Oxiplex® Gel in Spine Surgery
In July and Beyond: Honoring Bebe Moore Campbell's Legacy

As the nation marks Bebe Moore Campbell National Minority Mental Health Awareness Month this July, the National Alliance on Mental Illness (NAMI) honors the lasting impact of the late author, advocate, and NAMI Urban Los...

In July and Beyond: Honoring Bebe Moore Campbell's Legacy
State of Michigan Expands Naloxone Access with Generic Naloxone Nasal Spray from Hometown Manufacturer, Padagis

Padagis®, a Michigan-based leader in generic pharmaceuticals, announced today that the State of Michigan has added its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg to the state's distribution network. This...

State of Michigan Expands Naloxone Access with Generic Naloxone Nasal Spray from Hometown Manufacturer, Padagis
US RADIOLOGY SPECIALISTS REBRANDS AS LUMEXA IMAGING, USHERING IN A NEW ERA OF GROWTH AND TRANSFORMATION

US Radiology Specialists, Inc., one of the nation's largest providers of outpatient medical imaging, today announced it will begin operating under a new name: Lumexa Imaging™. This brand transformation marks a pivotal...

US RADIOLOGY SPECIALISTS REBRANDS AS LUMEXA IMAGING, USHERING IN A NEW ERA OF GROWTH AND TRANSFORMATION
Parkinson's Foundation Announces New Chief Medical Officer Leadership Role

The Parkinson's Foundation announced today the appointment of Sneha Mantri, MD, MS, as chief medical officer of the nation's leading organization dedicated to improving the lives of people with Parkinson's...

Parkinson's Foundation Announces New Chief Medical Officer Leadership Role
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone,...

Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
Insightec Announces FDA Approval of Staged Bilateral Focused Ultrasound Treatment for Parkinson's Disease

Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and Drug Administration (FDA) has approved the use of its Exablate Neuro platform...

Insightec Announces FDA Approval of Staged Bilateral Focused Ultrasound Treatment for Parkinson's Disease
Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced a strategic update highlighting its compelling clinical data from two tumor...

Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced that it has received formal notification from The Nasdaq Stock Market LLC ("Nasdaq") indicating that for 10 consecutive trading...

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs

Indivior PLC (Nasdaq / LSE: INDV) today announced the appointment of Vanessa Procter as Executive Vice President of Corporate Affairs, effective July 7, 2025. Vanessa is a seasoned corporate affairs leader with extensive...

Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs
Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo

Johnson & Johnson (NYSE:JNJ) announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) based upon long-term data evaluating the safety and efficacy of...

Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo
Cochlear Launches World's First and Only Smart Cochlear Implant System

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ Nucleus® Nexa™ System – the world's first and...

Cochlear Launches World's First and Only Smart Cochlear Implant System
Caristo to Unveil New Clinical and Research Results at SCCT 2025

Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, will unveil new clinical and research data on CaRi-Heart® technology - which measures coronary inflammation to predict...

Caristo to Unveil New Clinical and Research Results at SCCT 2025
Living Well With COPD: New Campaign Provides Critical Support and Resources to Families Across the Country Facing Common Lung Disease

The American Lung Association is launching a new campaign to support and empower individuals living with chronic obstructive pulmonary disease (COPD) in rural and other communities across the U.S.

Living Well With COPD: New Campaign Provides Critical Support and Resources to Families Across the Country Facing Common Lung Disease
UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community

UCB, a global biopharmaceutical company, today announced the expansion of its "Get Yourself Back" direct-to-consumer (DTC) advertising campaign for BIMZELX® (bimekizumab-bkzx). This campaign aims to raise awareness of...

UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
NUTEX HEALTH HOSPITALS' 2025 Q2 AWARDS

Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11...

NUTEX HEALTH HOSPITALS' 2025 Q2 AWARDS
The Cigna Group Foundation Addresses Mental Health and Housing Stability for Veterans with $3 Million in Grants

The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), announced today a new round of grants aimed at improving the mental health of military veterans. As part of a $9 million, three-year...

The Cigna Group Foundation Addresses Mental Health and Housing Stability for Veterans with $3 Million in Grants
West to Host Second-Quarter 2025 Conference Call

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter financial results before the market opens on...

West to Host Second-Quarter 2025 Conference Call
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities

WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently...

WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)

Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab) respectively, are commercially available in the United States.

Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration...

SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.

Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading vertically integrated pharmaceutical company based in China, today announced...

Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.
Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr., for Unilateral Vaccine Changes

Today, the American Academy of Pediatrics (AAP), American College of Physicians (ACP), American Public Health Association (APHA), Infectious Diseases Society of America (IDSA), Massachusetts Public Health Alliance (MPHA),...

Leading Medical Professional Societies, Patient Sue HHS, Robert F. Kennedy, Jr., for Unilateral Vaccine Changes
Tampa General Hospital and USF Health Successfully Perform World's First Recorded Bloodless Heart-Liver Transplant Surgery

Transplant surgeons at Tampa General Hospital (TGH) and USF Health have successfully performed the world's first recorded bloodless heart-liver transplant. The groundbreaking procedure was led by Dr. Kiran Dhanireddy,...

Tampa General Hospital and USF Health Successfully Perform World's First Recorded Bloodless Heart-Liver Transplant Surgery
APTA Releases New Report on Direct Access to Physical Therapist Services

The American Physical Therapy Association announces the release of the "State of Direct Access to Physical Therapist Services," a comprehensive resource designed to expand patient access to physical therapist services.

APTA Releases New Report on Direct Access to Physical Therapist Services
Orsini Selected as Specialty Pharmacy Partner for KalVista's EKTERLY® (sebetralstat)

Orsini, a leader in rare disease pharmacy solutions, has been chosen by KalVista Pharmaceuticals as a specialty pharmacy partner for EKTERLY® (sepiapterin), an FDA-approved oral therapy for the treatment of acute attacks...

Orsini Selected as Specialty Pharmacy Partner for KalVista's EKTERLY® (sebetralstat)
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide (https://ibn.fm/dyQrw) with these numbers expected to grow. The American Cancer Society...

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
BPS Announces Call for Nominations for 2026 BPS Awards

The Board of Pharmacy Specialties (BPS) announces the call for nominations for three BPS Awards: the BPS Rising Star Award, the BPS Weaver Penna Award, and the BPS Beacon Award. Nominations can be submitted here by the...

BPS Announces Call for Nominations for 2026 BPS Awards
Mind Lab Pro®'s Cognitive Benefits Confirmed in a UK Human Trial

Mind Lab Pro® v4.0, developed by Performance Lab® Group, has again been scientifically confirmed to produce excellent results.

Mind Lab Pro®'s Cognitive Benefits Confirmed in a UK Human Trial
OneOncology Appoints Dr. Michael Byrne as Medical Director for Cellular Therapy

OneOncology, a physician-led national platform empowering independent oncology practices, is pleased to appoint Michael Byrne, D.O. as Medical Director for Cellular Therapy.

OneOncology Appoints Dr. Michael Byrne as Medical Director for Cellular Therapy
Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food and Drug Administration (FDA) approved SIR-Spheres® Y-90 resin microspheres for the treatment of...

Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
A Leader in Quality: Hartford HealthCare's Hartford Surgery Center Earns Dual Advanced Orthopedic Certification in Total Joint Replacement and Complex Spine Surgery: a First in Connecticut

The Hartford HealthCare Hartford Surgery Center (HSC) has become the first ambulatory surgery center (ASC) in Connecticut, and one of only 10 in the nation to earn dual Advanced Orthopedic Certification in both Total Joint...

A Leader in Quality: Hartford HealthCare's Hartford Surgery Center Earns Dual Advanced Orthopedic Certification in Total Joint Replacement and Complex Spine Surgery: a First in Connecticut
QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has...

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs
The Voices of Persons Affected by Hansen's Disease Move the World: 3rd Global Forum Held in Bali, Indonesia

In a landmark gathering that placed lived experience at the center of global health discourse, the 3rd Global Forum of People's Organizations on Hansen's Disease was held in Bali, Indonesia, from July 4 to 6, 2025....

The Voices of Persons Affected by Hansen's Disease Move the World: 3rd Global Forum Held in Bali, Indonesia
Beko Recognised as One of TIME Magazine's Most Sustainable Companies in the World 2025

Leading global home appliance manufacturer Beko has been named one of TIME Magazine's World's Most Sustainable Companies for the second year running, earning a place in the Top 20 and securing the #1 position in...

Beko Recognised as One of TIME Magazine's Most Sustainable Companies in the World 2025
NetDragon Wins "Education Innovation & Technology- Rising Star Award" at the "2025 Hong Kong Sustainable Development Innovation and Technology Awards"

NetDragon Websoft Holdings Limited ("NetDragon" or the "Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that it wins the "Education Innovation & Technology...

NetDragon Wins "Education Innovation & Technology- Rising Star Award" at the "2025 Hong Kong Sustainable Development Innovation and Technology Awards"
Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial

During the COVID-19 pandemic, scientists learned that the critical path to infection started with the SARS-CoV-2 virus invading the nasal tissues of its victims, then causing millions of deaths by spreading through the...

Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial
BioLab Holdings, Inc. Launches Multicenter Clinical Trial to Evaluate Amnion Grafts for Chronic Wounds

BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and regenerative therapies, is pleased to announce the launch of a multicenter hybrid platform trial evaluating the clinical...

BioLab Holdings, Inc. Launches Multicenter Clinical Trial to Evaluate Amnion Grafts for Chronic Wounds
OMRON Healthcare Issues Urgent Health Message on AFib, Heart Failure Risks in Response to New Research

Heart health leader OMRON Healthcare today issued an urgent health message across the U.S. to raise public awareness of rapidly increasing risks and rising mortality rates associated with arrythmias such as atrial...

OMRON Healthcare Issues Urgent Health Message on AFib, Heart Failure Risks in Response to New Research
ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe

MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark, confirming compliance with European safety and performance standards. This important milestone expands access to...

ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, will extend High-Volume Hemodiafiltration (HighVolumeHDF) access for patients in seven out of 10...

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
Fangzhou Tops China's App Store Chart for Healthcare Apps

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, earned the top spot in the June 2025 China AppStore Healthcare TOP100 Free APP Rankings with its Fangzhou Online Pharmacy...

Fangzhou Tops China's App Store Chart for Healthcare Apps
New research by Alpharmaxim applies behavioural science to identify and understand prescribing choices in neurogenerative diseases - and highlights the need to optimise them

A groundbreaking new study, published in PLOS One, has uncovered key behavioural factors influencing how medications are prescribed to people living with neurodegenerative diseases. The findings raise important questions...

New research by Alpharmaxim applies behavioural science to identify and understand prescribing choices in neurogenerative diseases - and highlights the need to optimise them
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)

Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the first participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 13-week Phase IIa study of small...

Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30
INOVIO Announces Proposed Public Offering

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today...

INOVIO Announces Proposed Public Offering
Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the closing of its underwritten public offering...

Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
MANAMED® LLC Achieves ISO 13485 Certification, Reinforcing Commitment to Quality and Global Expansion

ManaMed LLC, a leading innovator in medical device solutions, proudly announces its certification to ISO 13485 by BSI®, a globally recognized standard for quality management systems in the medical device industry. This...

MANAMED® LLC Achieves ISO 13485 Certification, Reinforcing Commitment to Quality and Global Expansion
MiRus Siegel™ TAVR US Early Feasibility Study (EFS) 30 Day Results Presented at NY Valves Meeting

The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, Piedmont Heart Institute, Atlanta and Raj R. Makkar MD, Cedars Sinai Heart Institute, Los Angeles...

MiRus Siegel™ TAVR US Early Feasibility Study (EFS) 30 Day Results Presented at NY Valves Meeting
Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats

TORONTO, July 2, 2025 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept), a biosimilar to Eylea®,...

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats